Ethnic differences in prostate cancer

British Journal of Cancer

Volumn 105, Issue 4, 2011, Pages 481-485

  Kheirandish, P ^a,b   Chinegwundoh, F ^a,b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

aetiology; ethnicity; incidence rate; Prostate cancer

Indexed keywords

AFRICA; AFRICAN AMERICAN; ARTICLE; AWARENESS; CARIBBEAN ISLANDS; CLINICAL PRACTICE; ETHNIC DIFFERENCE; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; SYSTEMATIC REVIEW; UNITED KINGDOM; UNITED STATES;

AFRICA; AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; CARIBBEAN REGION; COST OF ILLNESS; DIETARY FATS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FOOD HABITS; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RISK FACTORS; TESTOSTERONE; UNITED STATES;

EID: 80051586122     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.273     Document Type: Article

References (41)

1. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Cazier JB, Sainz J, Jakobsdottir M, Kostic J, Magnusdottir DN, Ghosh S, Agnarsson K, Birgisdottir B, Le Roux L, Olafsdottir A, Blondal T, Andresdottir M, Gretarsdottir OS, Bergthorsson JT, Gudbjartsson D, Gylfason A, Thorleifsson G, Manolescu A, Kristjansson K, Geirsson G, Isaksson H, Douglas J, Johansson JE, Bälter K, Wiklund F, Montie JE, Yu X, Suarez BK, Ober C, Cooney KA, Gronberg H, Catalona WJ, Einarsson GV, Barkardottir RB, Gulcher JR, Kong A, Thorsteinsdottir U, Stefansson K (2006) A common variant associated with prostate cancer in European and African populations. Nat Genet 38: 652-658 (Pubitemid 43927306)
2. Aus G, Abbou CC, Bolla M, Heidenreich A, Schmid HP, van Poppel H, Wolff J, Zattoni F (2005) EAU guidelines on prostate cancer. Eur Urol 48: 546-551 (Pubitemid 41278578)
3. Ben-Shlomo Y, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F, Corbishley C, Dorling D, Thomas B, Gillatt D, Kirby R, Muir G, Nargund V, Popert R, Metcalfe C, Persad R (2008) The risk of prostate cancer amongst Black men in the United Kingdom: The PROCESS Cohort Study. Eur Urol 53: 99-105 (Pubitemid 350166704)
4. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297(8): 842-857 (Pubitemid 46333949)
5. Blake G, Hanchard B, Mitchell K, Simpson D, Waugh N, Wolff C, Samuels E (2002) Jamaica cancer mortality statistics, 1999. West Indian Med J 51: 64-67 (Pubitemid 34918939)
6. Chinegwundoh F, Enver M, Lee A, Nargund V, Oliver T, Ben-Shlomo Y (2006) Risk and presenting features of prostate cancer amongst African-Caribbean, South Asian and European men in North-east London. BJU Int 98: 1216-1220 (Pubitemid 44721227)
7. Committee on Diet, Nutrition and Cancer, Assembly of Life Sciences, National Research Council. (1982) Diet, Nutrition and Cancer. National Academy Press: Washington, DC
8. Easton DF, Eeles RA (2008) Genome-wide association studies in cancer. Hum Mol Genet 17: R109-R115
9. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW (2005) Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97(19): 1407-1427 (Pubitemid 41520077)
10. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, Mulholland S, Leongamornlert DA, Edwards SM, Morrison J, Field HI, Southey MC, Severi G, Donovan JL, Hamdy FC, Dearnaley DP, Muir KR, Smith C, Bagnato M, Ardern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Cox A, Lewis S, Brown PM, Jhavar SG, Tymrakiewicz M, Lophatananon A, Bryant SL, UK Genetic Prostate Cancer Study Collaborators; British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators, Horwich A, Huddart RA, Khoo VS, Parker CC, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Fisher C, Jamieson C, Cooper CS, English DR, Hopper JL, Neal DE, Easton DF. (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 40(3): 316-321 (Pubitemid 351311772)
11. Evans S, Metcalfe C, Ibrahim F, Persad R, Ben-Shlomo Y (2008) Investigating Black-White differences in prostate cancer prognosis: a systematic review and meta-analysis. Int J Cancer 123: 430-435 (Pubitemid 351842030)
12. Evans S, Metcalfe C, Patel B, Ibrahim F, Anson K, Chinegwundoh F, Corbishley C, Gillatt D, Kirby R, Muir G, Nargund V, Popert RP, Persad R, Ben-Shlomo Y (2010) Clinical presentation and initial management of Black men and White men with prostate cancer in the United Kingdom: the PROCESS cohort study. Br J Cancer 102: 249-254
13. Ferlay J, Shin HR, Bray F, Forman D, Mathers C. Parkin dmglobocan 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. accepted 2010
14. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, Waliszewska A, Penney K, Steen RG, Ardlie K, John EM, Oakley-Girvan I, Whittemore AS, Cooney KA, Ingles SA, Altshuler D, Henderson BE, Reich D (2006) Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci USA 103(38): 14068-14073 (Pubitemid 44452981)
15. Gann PH (1997) Interpreting recent trends in prostate cancer incidence and mortality. Epidemiology 8: 117-119
16. Glover Jr FE, Coffey DS, Douglas LL, Cadogan M, Russell H, Tulloch T, Baker TD, Wan RL, Walsh PC (1998) The epidemiology of prostate cancer in Jamaica. J Urol 159(6): 1986-1987
17. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, Helgason A, Rafnar T, Bergthorsson JT, Agnarsson BA, Baker A, Sigurdsson A, Benediktsdottir KR, Jakobsdottir M, Xu J, Blondal T, Kostic J, Sun J, Ghosh S, Stacey SN, Mouy M, Saemundsdottir J, Backman VM, Kristjansson K, Tres A, Partin AW, Albers-Akkers MT, Godino-Ivan Marcos J, Walsh PC, Swinkels DW, Navarrete S, Isaacs SD, Aben KK, Graif T, Cashy J, Ruiz-Echarri M, Wiley KE, Suarez BK, Witjes JA, Frigge M, Ober C, Jonsson E, Einarsson GV, Mayordomo JI, Kiemeney LA, Isaacs WB, Catalona WJ, Barkardottir RB, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 39(5): 631-637 (Pubitemid 46676102)
18. Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson JT, Thorleifsson G, Manolescu A, Rafnar T, Gudbjartsson D, Agnarsson BA, Baker A, Sigurdsson A, Benediktsdottir KR, Jakobsdottir M, Blondal T, Stacey SN, Helgason A, Gunnarsdottir S, Olafsdottir A, Kristinsson KT, Birgisdottir B, Ghosh S, Thorlacius S, Magnusdottir D, Stefansdottir G, Kristjansson K, Bagger Y, Wilensky RL, Reilly MP, Morris AD, Kimber CH, Adeyemo A, Chen Y, Zhou J, So WY, Tong PC, Ng MC, Hansen T, Andersen G, Borch-Johnsen K, Jorgensen T, Tres A, Fuertes F, Ruiz-Echarri M, Asin L, Saez B, van Boven E, Klaver S, Swinkels DW, Aben KK, Graif T, Cashy J, Suarez BK, van Vierssen Trip O, Frigge ML, Ober C, Hofker MH, Wijmenga C, Christiansen C, Rader DJ, Palmer CN, Rotimi C, Chan JC, Pedersen O, Sigurdsson G, Benediktsson R, Jonsson E, Einarsson GV, Mayordomo JI, Catalona WJ, Kiemeney LA, Barkardottir RB, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K (2007) Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 39(8): 977-983 (Pubitemid 47185170)
19. Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, Neubauer J, Tandon A, Schirmer C, McDonald GJ, Greenway SC, Stram DO, Le Marchand L, Kolonel LN, Frasco M, Wong D, Pooler LC, Ardlie K, Oakley-Girvan I, Whittemore AS, Cooney KA, John EM, Ingles SA, Altshuler D, Henderson BE, Reich D (2007) Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 39(5): 638-644 (Pubitemid 46676106)
20. Hanchard B, Blake G, Wolff C, Samuels E, Waugh N (2001) Age-specific incidence of cancer in Kingston and St Andrew, Jamaica, 1993-1997. West Indian Med J 50: 123-129 (Pubitemid 33611792)
21. Hsing AW, Comstock GW (1993) Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer. Cancer Epidemiol Biomarkers Prev 2(1): 27-32
22. Institute of Medicine (2001) Unequal Treatment, Confronting Racial and Ethnic Disparities in Healthcare. pp 1-764. The National Academies Press: Washington, DC
23. Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, Coltman C (2003) SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and design. Prostate Cancer Prostatic Dis 3(3): 145-151
24. Kolonel LN, Nomura AM, Cooney RV (1999) Dietary fat and prostate cancer: current status. J Natl Cancer Inst 91(5): 414-428 (Pubitemid 29128277)
25. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden 3rd JD, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens Jr FL, Baker LH, Coltman Jr CA (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301(1): 39-51
26. MacLean CH, Newberry SJ, Mojica WA, Khanna P, Issa AM, Suttorp MJ, Lim YW, Traina SB, Hilton L, Garland R, Morton SC (2006) Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA 295(4): 403-15 (Pubitemid 43144977)
27. Metcalfe C, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F, Corbishley C, Gillatt D, Kirby R, Muir G, Nargund V, Popert R, Persad R, Ben-Shlomo Y (2008) Pathways to diagnosis for Black men and White men found to have prostate cancer: the PROCESS cohort study. Br J Cancer 99: 1040-1045
28. Moyad MA (1999) Soy, disease prevention, and prostate cancer. Semin Urol Oncol 17(2): 97-102
29. Odedina FT, Akinremi T, Chinegwundoh F, Roberts R, Yu D, Reams R, Freedman M, Rivers B, Lee Green B, Kumar N (2009) Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa. Infect Agent Cancer 4(Suppl 1): S2; e-pub ahead of print 10 February 2009; doi:10.1186/1750-9378-4-S1-S2
30. Odedina FT, Ogunbiyi F, Ukoli F (2006) Prostate cancer burden in African-Americans: Can the origin be traced to Ancestral African relatives? J Natl Med Assoc 98: 539-543
31. Osegbe DN (1997) Prostate cancer in Nigerians: facts and nonfacts. J Urol 157(4): 1340-1343 (Pubitemid 27130810)
32. Parkin DM, Ferlay J, Hamdi-Cherif M, Sitas F, Thomas JO, Wabinga H, Whelan SL (2003) Cancer in Africa: Epidemiology and Prevention. 1st ed. IARC Scientific Publications: Lyon (France), No. 153
33. Ross RK, Bernstein L, Judd H, Hanisch R, Pike M, Henderson B (1986) Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst 76(1): 45-48 (Pubitemid 16156102)
34. Ross RK, Bernstein L, Lobo RA, Shimizu H, Stanczyk FZ, Pike MC, Henderson BE (1992) 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 11;339(8798): 887-889
35. Shapiro TM, Oliver ML (1996) Black wealth/White wealth: new perspective on racial inequality. Routledge: New York
36. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A, ERSPC Investigators (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360(13): 1320-1328
37. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, Crenshaw A, Cancel-Tassin G, Staats BJ, Wang Z, Gonzalez-Bosquet J, Fang J, Deng X, Berndt SI, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cussenot O, Valeri A, Andriole GL, Crawford ED, Tucker M, Gerhard DS, Fraumeni Jr JF, Hoover R, Hayes RB, Hunter DJ, Chanock SJ (2008) Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 40(3): 310-315 (Pubitemid 351311773)
38. US Cancer Statistics Working Group. (2005) United Statistics cancer statistics: 2002 incidence and mortality. US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute: Atlanta (GA)
39. Whitehead M (1994) Who cares about equity in the NHS? Br Med J 308: 1284-1287 (Pubitemid 24150286)
40. Wu AH, Whittemore AS, Kolonel LN, John EM, Gallagher RP, West DW, Hankin J, Teh CZ, Dreon DM, Paffenbarger Jr RS (1995) Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev 4(7): 735-741
41. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, Minichiello MJ, Fearnhead P, Yu K, Chatterjee N, Wang Z, Welch R, Staats BJ, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Gelmann EP, Tucker M, Gerhard DS, Fraumeni Jr JF, Hoover R, Hunter DJ, Chanock SJ, Thomas G (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39(5): 645-649 (Pubitemid 46676108)